Results about: neurodegenerative disease

New regulator of neuron formation identified

Researchers at IRB Barcelona reveal that the protein NEK7 is relevant for the correct formation of neurons in the hippocampus, a region of the brain associated with memory.

Animals without NEK7 may also have defects in other other brain regions.

Researchers develop a new class of covalent inhibitor for a protein involved in brain diseases

For the scientific community, the protein POP (prolyl oligopeptidase) is an attractive therapeutic target for the treatment of cognitive and neurodegenerative disorders.

Scientists at IRB Barcelona have developed the first POP inhibitors that are irreversible, selective and brain-permeable.

Ambulances for the brain supported by the RecerCaixa Programme

Gate2Brain is one of the projects to receive research funding from the Obra Social “la Caixa”

The results of the IRB Barcelona project could have applications in various neurodegenerative diseases

Of the 221 projects presented, only 26 have been awarded funding